Headache News and Research

Latest Headache News and Research

Analysis supports phase 3 trials of Johnson & Johnson's COVID-19 vaccine

Researchers in the Netherlands, the United States, and Belgium have presented early-stage clinical trial results demonstrating the safety and efficacy of Johnson & Johnson's vaccine candidate for coronavirus disease 2019 (COVID-19).

17 Jan 2021

CVS and Walgreens under fire for slow pace of vaccination in nursing homes

The effort to vaccinate some of the country's most vulnerable residents against covid-19 has been slowed by a federal program that sends retail pharmacists into nursing homes — accompanied by layers of bureaucracy and logistical snafus.

15 Jan 2021

No inflammation of cerebrospinal fluid in COVID-19 patients with neurological features, study finds

Many patients with COVID-19 have shown neurological complications, leading to scientific interest in the role played by its causative pathogen, SARS-CoV-2, in brain inflammation. A new study has described the absence of neuroinflammation in cerebrospinal fluid (CSF).

14 Jan 2021

Medicinal plant-derived compound destroys brain-eating amoeba in lab studies

Primary amoebic meningoencephalitis (PAM), a deadly disease caused by the "brain-eating amoeba" Naegleria fowleri, is becoming more common in some areas of the world, and it has no effective treatment.

13 Jan 2021

Hospitals’ rocky rollout of covid vaccine sparks questions of fairness

Last week, after finishing inoculations of some front-line hospital staff, Jupiter Medical Center was left with 40 doses of precious covid vaccine. So, officials offered shots to the South Florida hospital’s board of directors and their spouses over age 65.

13 Jan 2021

Headache as COVID-19 symptom could indicate milder disease, study finds

Researchers at the Hospital Universitario de La Princes in Madrid, Spain, found that patients with COVID-19 who developed headaches as an early symptom of infection had a milder illness and less risk of death.

12 Jan 2021

Multiple withdrawal symptoms experienced by people using medical marijuana for chronic pain

More than half of people who use medical marijuana products to ease pain also experience clusters of multiple withdrawal symptoms when they're between uses, a new study finds.

8 Jan 2021

Link between fever, diarrhea, severe COVID-19, and persistent anti-SARS-CoV-2 antibodies

A new preprint research paper appearing on the medRxiv server describes a link between the persistence of neutralizing antibodies against the virus, disease severity, and specific COVID-19 symptoms.

7 Jan 2021

Study shows durable specific humoral immunity against SARS-CoV-2 after mild or asymptomatic infection

As a part of the COMMUNITY (COVID-19 Immunity) study, researchers from Sweden reveal long-lasting IgG neutralizing antibody response against spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the vast majority of convalescent individuals – even after asymptomatic or mild infection. Their results are currently available on medRxiv* preprint server.

6 Jan 2021

Phase 3 results show investigational vaccine is effective in preventing severe COVID-19

The investigational vaccine known as mRNA-1273 was 94.1% efficacious in preventing symptomatic coronavirus disease 2019 (COVID-19), according to preliminary results from a Phase 3 clinical trial reported in the New England Journal of Medicine.

3 Jan 2021

COVID vaccines appear safe and effective, but key questions remain

The recent rollout of two newly authorized COVID-19 vaccines is a bright ray of hope at the pandemic's darkest hour.

23 Dec 2020

With few takers for COVID vaccine, DC hospital CEO takes ‘one for the team’

Administrators at Howard University Hospital in Washington, D.C., were thrilled to be among the city's first hospitals to get a COVID-19 vaccine, but they knew it could be a tough sell to get staffers to take the shot.

21 Dec 2020

FDA issues first emergency use authorization for second COVID-19 vaccine

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

21 Dec 2020

IU researchers receive $2.9 million grant to expand work on subconcussive impacts

Every year, nearly 2.5 million U.S. high school athletes participate in contact sports. Each of these athletes sustains an average of 650 subconcussive head impacts in a single season, hits that can negatively affect brain health.

18 Dec 2020

Vi-DT typhoid conjugate vaccine met primary endpoints in phase III study

Vi-DT typhoid conjugate vaccine, developed jointly by the International Vaccine Institute (IVI) and SK bioscience, has met the primary endpoints in a phase III study in Nepal.

17 Dec 2020

Mindfulness-based stress reduction may provide benefit to people with migraine

Migraine is a neurological disease that can be severely debilitating and is the second leading cause of disability worldwide.

14 Dec 2020

UK researchers examine university students behavior amid COVID-19 prevention measures

A team of UK-based researchers at the University of Bristol and the University of Exeter found that university students report fewer daily contacts amid the coronavirus pandemic. However, most of these contacts were those not affiliated with the university, indicating potential transmission to other people other than students and staff.

14 Dec 2020

Headache News and Research

Latest Headache News and Research

Analysis supports phase 3 trials of Johnson & Johnson's COVID-19 vaccine

CVS and Walgreens under fire for slow pace of vaccination in nursing homes

No inflammation of cerebrospinal fluid in COVID-19 patients with neurological features, study finds

Medicinal plant-derived compound destroys brain-eating amoeba in lab studies

Hospitals’ rocky rollout of covid vaccine sparks questions of fairness

Headache as COVID-19 symptom could indicate milder disease, study finds

Multiple withdrawal symptoms experienced by people using medical marijuana for chronic pain

Link between fever, diarrhea, severe COVID-19, and persistent anti-SARS-CoV-2 antibodies

Study shows durable specific humoral immunity against SARS-CoV-2 after mild or asymptomatic infection

Phase 3 results show investigational vaccine is effective in preventing severe COVID-19

COVID vaccines appear safe and effective, but key questions remain

With few takers for COVID vaccine, DC hospital CEO takes ‘one for the team’

FDA issues first emergency use authorization for second COVID-19 vaccine

IU researchers receive $2.9 million grant to expand work on subconcussive impacts

Vi-DT typhoid conjugate vaccine met primary endpoints in phase III study

Mindfulness-based stress reduction may provide benefit to people with migraine

UK researchers examine university students behavior amid COVID-19 prevention measures

Case study suggests kindergartens are not SARS-CoV-2 super-spreaders

COVID-19 infection may also affect the central nervous system, cause neurological disorders

D614/G614 variants of SARS-CoV-2 affect neuronal transmission; G614 better at membrane fusion

Pharmaceutical Manufacturing - Industry Focus eBook eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Headache News and Research

Latest Headache News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in